Medical Blog About Treatment Abroad

Pulmonary malignancy remains one of the leading causes of oncological mortality in the world, and that is why a correct understanding of the level of disease progression is critically important for both doctors and patients. Determining the level of spread of the disease is not a formality, but a key aspect that directly affects the prognosis, choice...

Lung cancer has been one of the most common causes of cancer death in the world for many decades. It is a serious global problem that affects millions of people. Non-small cell lung cancer is the most common type of cancer diagnosed, accounting for the majority of all cases. In the past, the prognosis for such patients was poor...

Colon cancer stage 4 is a form of colorectal cancer in which the cancer has spread beyond the colon and metastasized. The most common sites of involvement are the liver, lungs, peritoneum, ovaries, or distant lymph nodes. It is at this stage that the disease is no longer localized and requires a systemic, comprehensive approach to treatment.

Bowel cancer is a malignant tumor that develops in the large bowel, including the colon and rectum. It represents about 7.6% of all new cases of cancer in the USA and is fourth most common type of cancer. It often begins with a benign polyp that transforms into malignancy over time. About 15% to 40% of colon tumors originate from colon polyps...

Prostate cancer (PCa) remains the 2nd most frequently diagnosed malignancy among men, with approximately 1.5 million new cases reported per year. Radical prostatectomy (RP) is the basic treatment for localized disease, as according to the International Society of Urological Pathology (ISUP) grading system, Gleason score, etc.

Colorectal cancer (CRC), which comprises colon and/or rectum cancer, represents a significant health problem as the world’s third most commonly diagnosed and second most fatal cancer globally. Approximately 9.4% of cancer-related deaths were due to CRC in 2020. However, in light of the significant increase in the number of identified cases...

Prostate cancer (PCa) stands as the second most common cancer diagnosis among men worldwide. Each year brings approximately 299,000 new cases in the United States alone—representing 14.9% of all new cancer diagnoses. The five-year survival rate for localized PCa approaches 100%, while patients with regional disease maintain survival rates...

Thanks to the development of modern medicine prostate cancer is now effectively controlled and treated in most cases. Classical approaches to treatment (including radical prostatectomy, radiation therapy and hormonal therapy) have remained the standard for patients for many years. At the same time, such methods are often associated...